SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for NOVARTIS AG (NVS, NVSEF) (CIK 0001114448) (NVS) — Jul 22, 2015

NOVARTIS AG (NVS, NVSEF) (CIK 0001114448)
Date: July 22, 2015 · CIK: 0001114448 · Accession: 0000000000-15-038011

AI Filing Summary & Sentiment

File numbers found in text: 001-15024

Date
July 22, 2015
Author
/s/ Joel Parker
Form
UPLOAD
Company
NOVARTIS AG (NVS, NVSEF) (CIK 0001114448)

Letter

July 22, 2015 Via E-mail Mr. Felix R. Ehrat Group General Counsel Novartis AG Lichtstrasse 35 4056 Basel, Switzerland

Re: Novartis AG Form 20-F for Fiscal Year Ended December 31, 201 4 Filed January 27, 2015 File No. 001-15024

Dear Mr. Ehrat :

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are resp onsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Joel Parker

Show Raw Text
July 22,  2015

Via E-mail
Mr. Felix R. Ehrat
Group General Counsel
Novartis AG
Lichtstrasse 35
4056 Basel, Switzerland

Re: Novartis AG
  Form 20-F for Fiscal Year Ended December 31, 201 4
  Filed January 27, 2015
  File No. 001-15024

Dear  Mr. Ehrat :

We have completed our review of your filing. We remind you that our comments
or changes to disclosure in response to our comments do not foreclose the Commission
from taking any action with respect to the company or the filing and the company may
not assert staff comments as a defense in any proceeding initiated by the Commission or
any person under the federal securities laws of the United States. We urge all persons
who are resp onsible for the accuracy and adequacy of the disclosure in the filing to be
certain that the filing includes the information the Securities Exchange Act of 1934 and
all applicable rules require.

Sincerely,

 /s/ Joel Parker

Joel Parker
Accounting Branch Chief